openPR Logo
Press release

Beeline Holdings (NASDAQ: BLNE) Introduces Stablecoin-Driven Next-Gen Home Mortgage - More Stocks Inside

06-25-2025 04:40 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Beeline Holdings (NASDAQ: BLNE) Introduces Stablecoin-Driven

Beeline Holdings, Inc. (NASDAQ: BLNE), a pioneering mortgage fintech company, recently announcing the successful closing of its first-ever fractional equity home sale leveraging a stablecoin-based transaction model. This innovative approach offers a compelling alternative to traditional mortgages by removing interest rate dependencies and enabling faster, blockchain-backed homeownership solutions. Press Release dated June 25, 2025 [https://app.quotemedia.com/data/downloadFiling?type=HTML&webmasterId=501&ref=319261357#ex99-1.htm]

The transaction marks the first in a series of five to ten beta deals scheduled over the coming weeks ahead of a national rollout set for early August 2025. Beeline's model combines AI-powered underwriting with a digital title platform, allowing for seamless property transactions with more financial flexibility. See 8k [https://app.quotemedia.com/data/downloadFiling?type=HTML&webmasterId=501&ref=319250918]

As it accelerates toward national scale, Beeline Holdings, Inc. (NASDAQ: BLNE) joins a dynamic group of public companies under $5-including QuantumScape Corp. (NYSE: QS), Urgent.ly Inc. (NASDAQ: ULY), Peraso Inc. (NASDAQ: PRSO), Health In Tech Inc. (NASDAQ: HIT), and Synergy CHC Corp. "Focusfactor" (NASDAQ: SNYR)-all positioned to lead the next wave of market-defining disruption across sectors like fintech, clean energy, AI infrastructure, and consumer health.

"This innovation redefines what it means to own a home," said a company spokesperson. "By utilizing blockchain and stablecoins, we're making the process faster, more secure, and more accessible."

Headquartered in Providence, Rhode Island, Beeline is transforming the mortgage landscape with its AI-driven digital lending platform, empowering individuals to achieve greater financial freedom through property equity-not debt.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=beeline-holdings-nasdaq-blne-introduces-stablecoindriven-nextgen-home-mortgage-more-stocks-inside]
Country: United States
Website: http://www.thestreetreports.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Beeline Holdings (NASDAQ: BLNE) Introduces Stablecoin-Driven Next-Gen Home Mortgage - More Stocks Inside here

News-ID: 4082074 • Views:

More Releases from ABNewswire

Pulmonary Arterial Hypertension Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Ribomic, Gmax Biopharm, Novartis, Cereno Scientific AB, Insmed
Pulmonary Arterial Hypertension Pipeline 2025: MOA and ROA Insights, Clinical Tr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Pulmonary Arterial Hypertension pipeline constitutes 55+ key companies continuously working towards developing 55+ Pulmonary Arterial Hypertension treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Pulmonary Arterial Hypertension Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/pulmonary-arterial-hypertension-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Pulmonary Arterial Hypertension Market. The
Growth Hormone Deficiency Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Novo Nordisk, Ascendis Pharma, Double Point Ventures (Lumos Pharma), SCOHIA PHARMA
Growth Hormone Deficiency Market Predicted to See Upsurge Through 2034, Highligh …
The Key Growth Hormone Deficiency Companies in the market include - Novo Nordisk, Ascendis Pharma, Double Point Ventures (Lumos Pharma), SCOHIA PHARMA, and others. The Growth Hormone Deficiency market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize the Growth Hormone Deficiency market dynamics. DelveInsight's "Growth Hormone Deficiency Market Insights, Epidemiology, and Market Forecast-2034 report offers
Diffuse Large B-cell Lymphoma Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Xynomic Pharma, Hanmi Pharma, S IMV Inc. Seagen
Diffuse Large B-cell Lymphoma Pipeline 2025: FDA Updates, Therapy Innovations, a …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diffuse Large B-cell Lymphoma pipeline constitutes 70+ key companies continuously working towards developing 75+ Diffuse Large B-cell Lymphoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Diffuse Large B-cell Lymphoma Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/diffuse-large-b-cell-lymphoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Diffuse
Follicular Lymphoma Pipeline 2025: Mechanism of Action, Route of Administration, and Clinical Trial Insights Explored by DelveInsights | AstraZeneca, InnoCare Pharma, Allogene Therapeutics, HUTCHMED
Follicular Lymphoma Pipeline 2025: Mechanism of Action, Route of Administration, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Follicular Lymphoma pipeline constitutes 45+ key companies continuously working towards developing 50+ Follicular Lymphoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Follicular Lymphoma Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/follicular-lymphoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Follicular Lymphoma Market. The Follicular Lymphoma Pipeline report

All 5 Releases


More Releases for NASDAQ:

Zillow Group, Inc. (NASDAQ: Z, NASDAQ: ZG) Investor Notice: Update in Lawsuit ag …
The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in Zillow Group, Inc. (NASDAQ: Z, NASDAQ: ZG). Investors who purchased shares of Zillow Group, Inc. (NASDAQ: Z, NASDAQ: ZG) and currently hold any of those NASDAQ: MTCH shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On November 16, 2021, a lawsuit was filed against Zillow Group,
Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) Investor Alert: Deadline in Lawsu …
A deadline is coming up on March 8, 2022in the lawsuit filed for certain investors of Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) over alleged securities laws violations by Goldman Sachs and Morgan Stanley Investors who purchased shares of Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) have certain options and there are strict and short deadlines running. Deadline: March 8, 2022. Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) stockholders should contact the Shareholders Foundation
Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) Investor Notice: Lawsuit alleges …
An investor, who purchased shares of Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws. Investors who purchased a significant amount of shares of Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) between March 22, 2021 and March 29, 2021, have certain options and for certain investors are short and strict deadlines running. Deadline:
Investigation for NASDAQ: FREQ Investors over possible Wrongdoing at Frequency T …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Frequency Therapeutics, Inc. Investors who purchased shares of Frequency Therapeutics, Inc. (NASDAQ: FREQ) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Frequency Therapeutics, Inc. (directors breached their fiduciary duties and caused damage to the company and its shareholders. Woburn,
Investigation announced for Investors in shares of Alphabet Inc. (NASDAQ: GOOG, …
An investigation was announced on behalf of investors of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL) shares over potential securities laws violations by Alphabet Inc. in connection with certain financial statements. Investors who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers
Oncolytic Virus Therapy Market 2020 Research and Clinical Analysis - Amgen(NASDA …
"Global Oncolytic Virus Therapy Market Report 2020-2026" helps the clients to take business decisions and to understand strategies of major players in the industry. The report also calls for market - driven results deriving feasibility studies for client needs. Marketinsightsreports ensures qualified and verifiable aspects of market data operating in the real- time scenario. The analytical studies are conducted ensuring client needs with a thorough understanding of market capacities in